Swiss company with expertise in plasma medicine

By developing and manufacturing innovative, easily manageable cold plasma therapy pens, the ActivCell Group is promoting the establishment of plasma medicine as an efficient treatment method in everyday medical practice. In cooperation with renowned European technology institutes and universities, ActivCell Group AG is making an important contribution to the research and ongoing development of this future-focused form of therapy in human and veterinary medicine.

The ActivCell-team

Michael Hiestand, Dr med vet

Director of Veterinary Division
Member of the Board of Directors
Member of the Executive Board

CV

Daniele Scarabello, MSc

Finance & Supply Chain Manager, Administration

CV

Selina Keller, Dr med vet

Product and Sales Manager, Veterinary Division

CV

Thomas Fünfschilling, <b>Dipl Ing ETH </b>

Thomas Fünfschilling, Dipl Ing ETH

Advisor R&D

CV

Urs Laubscher

Advisor R&D and Production Technology

CV

Board of Directors

Ruedi Weber

Founder and President of the Board of Directors
Former Founder and Managing Director SIA/SWB, previously Ruedi Weber + Architekten und Planer AG

CV

Peter Weber

Founder and Member of the Board of Directors
President of the Board of Directors peka-metall AG

CV

Peter Frei, Dipl Ing FH

Founder and Member of the Board of Directors
Manager and Owner IQF LLC

CV

Dominik Lysek, PhD

Member of the Board of Directors
Partner Let’s Innovate

CV

Michael Hiestand, DVM

Member of the Board of Directors
Owner and Managing Director Kleintierpraxis am Obersee GmbH
Member of the Board of Directors ACTIV’GLASS/ISSOL Schweiz AG

CV

Veterinary Advisory Board

Verena Denise Bracher

DVM, PhD

CV

Claudia Nett

DVM, Dipl ACVD & EBVS^® European Specialist in Veterinary Dermatology

CV

Adrian Steiner

Prof DVM, FVH, ECVS, ECBHM

CV

Heinz W. Burkhardt

DVM, FVH

CV

Michael Hiestand

DVM

CV

Careers at ActivCell Group AG

The ActivCell Group is a dynamic start-up company. We develop, produce and distribute innovative mobile cold plasma therapy devices in the form of handy pens.

Positions to be filled:

No vacancies at the moment

Unfortunately, we do not have any vacancies at the moment. However, we are always happy to receive unsolicited applications.

The history of the ActivCell Group

The motivation for founding ActivCell arose from the founders’ own experience with illness. Brothers Peter and Ruedi Weber struggled with ailments that were difficult to treat and did not respond to conventional therapies. In their search for alternatives, they came across high-frequency electrotherapy and experienced impressive healing successes.

Convinced that this therapy should have a more significant place in the medical world, Peter and Ruedi Weber decided to have the technology and its mechanisms of action researched and transferred into practice. At that time, there were no handy, mobile devices approved for medical use on the market for this form of therapy.

Determined to change this situation, Ruedi and Peter Weber founded ActivCell AG in 2014 together with Swiss engineers and scientists from the fields of medical technology and industrial design. The first handy, cordless prototypes for veterinary medicine were quickly developed.

The fact that these devices were also excellent sources of cold plasma and promised great benefits for the emerging field of plasma medicine gave clear direction to the disciplines of research and development for both veterinary and human medicine.

In 2017, the company launched its first devices for veterinary medicine. The devices were further developed according to market requirements and relaunched in 2020.

In the same year, ActivCell AG was renamed ActivCell Group AG and started the approval process for the use of the ActivCellpen in human medicine.